CD44 and breast carcinoma: Clinical studies have also hinted at the impact of doxycycline on the cancer stem cell compartment; pre-operative administration of the drug to patients with breast cancer led to reduced expression of the stemness markers CD44 and ALDH1 in tumors compared with matched pre-treatment biopsies [26].